Additional Coverage:
- Trump’s Tariffs Could Double the Price of Ozempic and These Other Drugs (financebuzz.com)
Prescription Drug Tariffs: What Seniors Need to Know About Rising Medication Costs
Prescription drug expenses are already a significant concern for many, especially those managing long-term health conditions. Recent tariffs introduced by the previous administration may further increase costs for certain medications imported into the United States, potentially impacting your healthcare budget and retirement planning.
Understanding the New Pharmaceutical Tariffs
As of July 31, 2026, a 100% tariff was imposed on numerous imported patented drugs and their key components. Seventeen pharmaceutical companies were given a limited window to negotiate agreements to either manufacture these drugs domestically or adjust pricing to avoid the tariff. Compliance with such agreements can reduce or eliminate the tariff burden.
Notably, generic and biosimilar drugs remain exempt from these tariffs until July 31, 2028. However, patients relying on brand-name medications may experience immediate price increases.
Medications Most Affected by the Tariffs
Drugs produced overseas by companies without negotiated agreements face the full tariff, potentially doubling costs. Examples include:
- Entresto, used for heart failure
- Keytruda, a cancer immunotherapy
- Lenvima, for certain cancers
- Ozempic and Wegovy, for diabetes and weight management
For those without insurance, monthly costs for some of these medications could increase by hundreds or even thousands of dollars.
Case in Point: Entresto’s Price Surge
Currently, a 60-tablet supply of Entresto costs between approximately $889 and $969 without insurance. The tariff could raise this price to between $1,434 and $1,938.
Since Entresto is commonly prescribed as a first-line treatment, demand is expected to remain steady. Patients with insurance may also face higher copays or coinsurance as pharmacies adjust to increased wholesale costs.
Negotiated Exemptions for Some Drugs
Keytruda’s manufacturer, Merck, secured a three-year exemption by agreeing to Most-Favored-Nation (MFN) pricing and domestic operational incentives. Similarly, Novo Nordisk reached agreements to move production of Ozempic and Wegovy to the U.S., avoiding tariff imposition.
Why Brand-Name Drugs Are Most Impacted
The tariffs target patented medications and their ingredients, leaving generics untouched for now. Given that generics account for over 90% of U.S. prescriptions, the financial impact is most acute for patients who rely on newer, brand-name drugs without generic alternatives.
Perspectives on the Tariffs
Supporters of the tariffs argue that incentivizing domestic manufacturing will reduce dependence on foreign supply chains, create American jobs, and eventually lead to lower drug prices and improved national security.
Critics, however, caution that these tariffs may cause immediate price hikes before new domestic facilities come online. Higher costs could lead to patients delaying or foregoing essential treatments. Additionally, there are concerns about increased insurance premiums and strain on government healthcare programs.
Insurance Coverage and Your Out-of-Pocket Costs
While insurance plans may absorb some cost increases, patients could still encounter higher premiums, copays, or deductibles. Medicare Part D beneficiaries might face increased expenses during the coverage gap. Those paying cash or with high-deductible plans are likely to feel the full impact immediately.
Practical Steps to Manage Rising Drug Costs
To mitigate potential price hikes, consider the following:
- Consult your healthcare provider about switching to generic or biosimilar alternatives where feasible.
- Review your insurance formulary to identify covered options.
- Utilize available discount programs or manufacturer assistance.
Taking proactive measures can help you maintain your treatment regimen without undue financial strain.
In Summary
The pharmaceutical tariffs represent a significant shift in drug pricing policy, with potential short-term cost increases for many patients, particularly those using imported brand-name medications. While the goal is to encourage domestic production and ultimately lower prices, immediate effects may include higher out-of-pocket expenses.
If you are impacted, exploring manufacturer assistance programs and staying informed about changes to your medication coverage can help manage costs effectively.
Financial Tips for Seniors Facing Rising Expenses
Beyond managing drug costs, consider strategies to strengthen your financial health:
- Increase income through part-time work or side jobs compatible with your schedule.
- Grow your savings by leveraging compound interest and seeking professional financial advice.
- Maximize available discounts and benefits tailored for seniors, such as insurance savings and money-saving programs.
Staying proactive with both your healthcare and finances can help you navigate these changes with greater confidence.
Read More About This Story:
- Trump’s Tariffs Could Double the Price of Ozempic and These Other Drugs (financebuzz.com)